Alchemab bags fresh round of in­vestors for tar­get-ag­nos­tic an­ti­body de­vel­op­ment for Hunt­ing­ton's, Covid-19

5 years ago
Financing
R&D

The world of Wnt heads to Nas­daq as Sur­rozen an­nounces a $212M SPAC deal

5 years ago
Financing

Roche touts 2-year ef­fi­ca­cy da­ta for SMA ther­a­py Evrys­di; NIH funds new net­work to study flu and virus­es with ...

5 years ago
News Briefing

PDU­FA VII to ex­pand FDA’s re­al-time on­col­o­gy re­views to sup­ple­ments for all ther­a­peu­tic ar­eas

5 years ago
FDA+

Ac­tivist in­vestor grabs a multi­bil­lion-pound stake in Glax­o­SmithK­line, trig­ger­ing buzz about a loom­ing show­down at ...

5 years ago
Bioregnum
R&D

Af­ter a ma­jor facelift, Al­tru­Bio says it's ready for a piv­otal fight against graft-ver­sus-host dis­ease

5 years ago
Financing

Glax­o­SmithK­line’s head of vac­cine R&D is jump­ing to a well­ness com­pa­ny con­cen­trat­ing on the mi­cro­bio­me as re­ports ...

5 years ago
People

Mer­ck scraps their $425M Covid-19 drug in lat­est pan­dem­ic set­back

5 years ago
R&D
Coronavirus

Eli Lil­ly ax­es 163 Der­mi­ra staffers, shut­ters Men­lo Park site as it clos­es in around Dupix­ent ri­val le­brik­izum­ab

5 years ago
People
Pharma

With a new method to syn­the­size DNA, San Diego's Mol­e­c­u­lar As­sem­blies notch­es $24M Se­ries A

5 years ago
Financing

Har­vard bil­lion­aire Tim Springer has lined up his lat­est biotech launch. And he's re­cruit­ed a star R&D ex­ec to man­age ...

5 years ago
Startups

Spon­sors should flag de­cen­tral­ized as­pects of can­cer tri­als to prep for the post-Covid era, FDA says

5 years ago
FDA+
Coronavirus

Covid-19 roundup: J&J shot re­mains on hold af­ter CDC pan­el vote

5 years ago
R&D

Glax­o­SmithK­line scraps two key mid-stage tri­als for their ICOS drug in the lat­est set­back for the field

5 years ago
R&D

An­oth­er big CRO deal has land­ed as Ther­mo Fish­er ac­quires PPD for $17.4B

5 years ago
Deals

Up­dat­ed: Al­ny­lam faces DOJ probe over On­pat­tro mar­ket­ing

5 years ago
Pharma

Ex­clu­sive in­ter­view: Pe­ter Marks on why full Covid-19 vac­cine ap­provals could be just months away

5 years ago
FDA+
Coronavirus

Janet Wood­cock on if the FDA is get­ting tougher on drug re­views: ‘I don’t think so’

5 years ago
Pharma
FDA+

Meet Bench­ling, the lat­est uni­corn seek­ing to rev­o­lu­tion­ize the way sci­en­tists do work with the help of the cloud

5 years ago
Financing

Covid-19 roundup: No­vavax shakes up lead­er­ship with two pro­mo­tions and de­par­ture of CFO; Mod­er­na, No­vavax shots added ...

5 years ago
Coronavirus

Amy­lyx to move for­ward with ALS pro­gram in Eu­rope, but FDA wants an­oth­er look; Hu­ma­cyte adds $50M in debt fi­nanc­ing

5 years ago
News Briefing

The right to vote is fun­da­men­tal — a let­ter from biotech­nol­o­gy in­dus­try lead­ers

5 years ago
People
Biotech Voices

Launched by MIT grads, a small start­up gets $20M to back a ro­bot­ics rev­o­lu­tion in cell ther­a­py man­u­fac­tur­ing

5 years ago
Startups
Manufacturing

Near­ly a year af­ter Au­den­tes' gene ther­a­py deaths, the tri­al con­tin­ues. What hap­pened re­mains a mys­tery

5 years ago
Cell/Gene Tx
In Focus
First page Previous page 707708709710711712713 Next page Last page
A service from the Financial Times